Literature DB >> 1449809

Modulation of eosinophil chemotaxis by interleukin-5.

R A Warringa1, R C Schweizer, T Maikoe, P H Kuijper, P L Bruijnzeel, L Koendermann.   

Abstract

Eosinophilia and eosinophil function are regulated by cytokines such as granulocyte/macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and interleukin-5 (IL-5). We have investigated the modulatory role of IL-5 on N-formyl-methionyl-leucyl-phenylalanine (FMLP), neutrophil-activating factor (NAF/IL-8), platelet factor 4 (PF4), and cytokine-induced chemotaxis of eosinophils from normal individuals. These eosinophils show a small chemotactic response toward PF4 but not to NAF/IL-8 and FMLP. Preincubation of eosinophils with low concentrations of IL-5 caused significantly increased responses toward PF4 and induced a significant chemotactic response toward FMLP and NAF/IL-8. In marked contrast, IL-5 (or IL-3) priming of eosinophils from normal donors resulted in a strong inhibition of GM-CSF-induced chemotaxis. A similar decrease in the chemotactic response toward GM-CSF was observed in eosinophils derived from allergic asthmatic individuals. This finding suggests that the latter eosinophils may have had a prior exposure to IL-5 (or IL-3). Washing of the cells after priming did not abrogate the inhibition of the GM-CSF response. Our data indicate that at low concentrations IL-5 is an important modulator of eosinophil chemotaxis, causing selective upregulation or downregulation of chemotactic responses toward different agents.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1449809     DOI: 10.1165/ajrcmb/7.6.631

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  20 in total

1.  IL-5 induces suspended eosinophils to undergo unique global reorganization associated with priming.

Authors:  Shih-Tsung Han; Deane F Mosher
Journal:  Am J Respir Cell Mol Biol       Date:  2014-03       Impact factor: 6.914

2.  Cytokines induce selective granulocyte chemotactic responses.

Authors:  D B Bittleman; R A Erger; T B Casale
Journal:  Inflamm Res       Date:  1996-02       Impact factor: 4.575

Review 3.  Eosinophils and disease pathogenesis.

Authors:  Praveen Akuthota; Peter F Weller
Journal:  Semin Hematol       Date:  2012-04       Impact factor: 3.851

Review 4.  Inflammatory cells in the airways in COPD.

Authors:  R O'Donnell; D Breen; S Wilson; R Djukanovic
Journal:  Thorax       Date:  2006-05       Impact factor: 9.139

Review 5.  The eosinophil leukocyte: controversies of recruitment and function.

Authors:  L P Bignold
Journal:  Experientia       Date:  1995-04-15

Review 6.  Eosinophils: multifaceted biological properties and roles in health and disease.

Authors:  Hirohito Kita
Journal:  Immunol Rev       Date:  2011-07       Impact factor: 12.988

Review 7.  Eosinophilic pneumonias.

Authors:  Praveen Akuthota; Peter F Weller
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

8.  Human eosinophils express functional CCR7.

Authors:  Praveen Akuthota; Shigeharu Ueki; Jessica Estanislau; Peter F Weller
Journal:  Am J Respir Cell Mol Biol       Date:  2013-06       Impact factor: 6.914

9.  Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils.

Authors:  N Zimmermann; M L McBride; Y Yamada; S A Hudson; C Jones; K D Cromie; P R Crocker; M E Rothenberg; B S Bochner
Journal:  Allergy       Date:  2008-09       Impact factor: 13.146

10.  Eosinophil accumulation induced by human interleukin-8 in the guinea-pig in vivo.

Authors:  P D Collins; V B Weg; L H Faccioli; M L Watson; R Moqbel; T J Williams
Journal:  Immunology       Date:  1993-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.